Literature DB >> 23666663

Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010.

Iúri Paz Lima1, Marina Costa Müller, Thiago Ayres Holanda, Michael Harhay, Carlos Henrique Nery Costa, Dorcas Lamounier Costa.   

Abstract

INTRODUCTION: Human immunodeficiency virus (HIV) coinfection with Leishmania infantum or Leishmania donovani, the agents of visceral leishmaniasis (or kala-azar), has become a fatal public health problem in the tropics where kala-azar is endemic.
METHODS: The clinical presentation of patients with HIV and L. infantum coinfection is described using two unique databases that together produce the largest case series of patients with kala-azar infected with HIV in South America. First, a retrospective study paired the list of all patients with kala-azar from 1994 to 2004 with another of all patients with HIV/AIDS from the reference hospital for both diseases in the City of Teresina, State of Piauí, Brazil. Beginning in 2005 through to 2010 this information was prospectively collected at the moment of hospitalization.
RESULTS: During the study, 256 admissions related to 224 patients with HIV/L. infantum coinfection were registered and most of them were males between 20-40 years of age. Most of the 224 patients were males between 20-40 years of age. HIV contraction was principally sexual. The most common symptoms and signs were pallor, fever, asthenia and hepatosplenomegaly. 16.8% of the cohort died. The primary risk factors associated to death were kidney or respiratory failure, somnolence, hemorrhagic manifestations and a syndrome of systemic inflammation. The diagnosis of HIV and kala-azar was made simultaneously in 124 patients.
CONCLUSIONS: The urban association between HIV and kala-azar coinfection in South America is worrisome due to difficulty in establishing the diagnosis and higher mortality among the coinfected then those with either disease independently. HIV/L. infantum coinfection exhibits some singular characteristics and due to its higher mortality it requires immediate assistance to patients and greater research on appropriate combination therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23666663     DOI: 10.1590/0037-8682-0033-2012

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  10 in total

1.  Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.

Authors:  Diego Lins Guedes; Zulma Medeiros; Elis Dionísio da Silva; Audrey Violeta Martins de Vasconcelos; Mariana Santana da Silva; Maria Almerice Lopes da Silva; Paulo Sérgio Ramos de Araújo; Demócrito de Barros Miranda-Filho
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

2.  Splenectomy in Patients with Visceral Leishmaniasis Resistant to Conventional Therapy and Secondary Prophylaxis: A Retrospective Cohort.

Authors:  Luis G C Reinaldo; Raimundo J C Araújo-Júnior; Thiago M Diniz; Rafael D Moura; Antônio J Meneses-Filho; Caio V V M Furtado; Washington L C Santos; Dorcas L Costa; Kelsen D Eulálio; Gabriel R Ferreira; Carlos H N Costa
Journal:  Am J Trop Med Hyg       Date:  2022-06-20       Impact factor: 3.707

3.  Risk Factors for Death from Visceral Leishmaniasis in an Urban Area of Brazil.

Authors:  Angelita F Druzian; Albert S de Souza; Diogo N de Campos; Julio Croda; Minoru G Higa; Maria Elizabeth C Dorval; Mauricio A Pompilio; Polliana A de Oliveira; Anamaria M M Paniago
Journal:  PLoS Negl Trop Dis       Date:  2015-08-14

4.  Post-kala-azar dermal Leishmaniasis in two different clinical contexts.

Authors:  Daniel Holanda Barroso; Claúdia Elise Ferraz Silva; Ana Carolina Depes Perdigao e Vasconcelos; Silvana Maria de Morais Cavalcanti; Maria Edileuza Felinto de Brito; Angela Cristina Rapela Medeiros
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

Review 5.  Visceral leishmaniasis and HIV coinfection in Latin America.

Authors:  José Angelo Lindoso; Gláucia Fernandes Cota; Alda Maria da Cruz; Hiro Goto; Ana Nilce Silveira Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Márcia Leite de Sousa-Gomes; Joanna Reis Santos-Oliveira; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

Review 6.  Leishmaniasis-HIV coinfection: current challenges.

Authors:  José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira
Journal:  HIV AIDS (Auckl)       Date:  2016-10-07

Review 7.  Visceral leishmaniasis and HIV coinfection: current perspectives.

Authors:  José Angelo Lauletta Lindoso; Carlos Henrique Valente Moreira; Mirella Alves Cunha; Igor Thiago Queiroz
Journal:  HIV AIDS (Auckl)       Date:  2018-10-15

8.  Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?

Authors:  Uiara Regina Silva de Lima; Luciano Vanolli; Elizabeth Coelho Moraes; Jorim Severino Ithamar; Conceição de Maria Pedrozo E Silva de Azevedo
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

9.  Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review.

Authors:  Mekuriaw Alemayehu; Mamo Wubshet; Nebiyu Mesfin
Journal:  HIV AIDS (Auckl)       Date:  2016-03-23

10.  Is Visceral Leishmaniasis the same in HIV-coinfected adults?

Authors:  Guilherme Alves de Lima Henn; Alberto Novaes Ramos Júnior; Jeová Keny Baima Colares; Lorena Pinho Mendes; João Gabriel Colares Silveira; Anderson Alberto Façanha Lima; Bárbara Pontes Aires; Mônica Cardoso Façanha
Journal:  Braz J Infect Dis       Date:  2018-03-27       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.